Access to anti-retroviral drugs, male in Paraguay
Paraguay: Access to anti-retroviral drugs, male was 61.0% in 2024. ◆ Volatile
Access to anti-retroviral drugs, male in Paraguay, 2000–2024
Source: UNAIDS estimates. Measured in %.
Analysis
The most recent figure for access to anti-retroviral drugs, male in Paraguay is 61.0%, measured in 2024. That is the highest value across all 25 years on record.
The figure is up 3.4% on the previous year and up 103.3% over ten years.
Over the whole period, access to anti-retroviral drugs, male in Paraguay peaked at 61.0% in 2024 and was at its lowest, 0.0%, in 2000.
Paraguay ranks 97th of 141 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Access to anti-retroviral drugs, male in Paraguay, year by year
| Year | % | Change |
|---|---|---|
| 2000 | 0.0% | — |
| 2001 | 0.0% | — |
| 2002 | 0.0% | — |
| 2003 | 0.0% | — |
| 2004 | 0.0% | — |
| 2005 | 6.0% | — |
| 2006 | 9.0% | +50.0% |
| 2007 | 12.0% | +33.3% |
| 2008 | 16.0% | +33.3% |
| 2009 | 21.0% | +31.2% |
| 2010 | 25.0% | +19.0% |
| 2011 | 24.0% | -4.0% |
| 2012 | 24.0% | +0.0% |
| 2013 | 28.0% | +16.7% |
| 2014 | 30.0% | +7.1% |
| 2015 | 33.0% | +10.0% |
| 2016 | 37.0% | +12.1% |
| 2017 | 44.0% | +18.9% |
| 2018 | 46.0% | +4.5% |
| 2019 | 49.0% | +6.5% |
| 2020 | 50.0% | +2.0% |
| 2021 | 54.0% | +8.0% |
| 2022 | 57.0% | +5.6% |
| 2023 | 59.0% | +3.5% |
| 2024 | 61.0% | +3.4% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 6.4% | 0.0% | 21.0% | 10 |
| 2010s | 34.0% | 24.0% | 49.0% | 10 |
| 2020s | 56.2% | 50.0% | 61.0% | 5 |
Countries ranked near Paraguay
- 94 Bhutan 62.0% compare
- 94 Guinea-Bissau 62.0% compare
- 94 Timor-Leste 62.0% compare
- 97 Central African Republic 61.0% compare
- 97 Costa Rica 61.0% compare
- 97 Lao People's Democratic Republic 61.0% compare
- 97 Montenegro 61.0% compare
More gender data for Paraguay
- Child population (UN estimates and projections) 1,993 (2030)
- Child population (UN estimates and projections) (0-14), annual growth -0.2942 % change on previous year (2030)
- Population 5,415 (2030)
- Working-age population (UN estimates and projections) 5,415 (2030)
- Population (UN estimates and projections), annual growth rate 1.53 % change on previous year (2030)
- Age population, age 00, female, interpolated 65,495 (2025)
- Age population, age 00, male, interpolated 68,548 (2025)
- Age population, age 01, female, interpolated 65,498 (2025)
- Age population, age 01, male, interpolated 68,560 (2025)
- Age population, age 02, female, interpolated 65,610 (2025)
Frequently asked questions
- What is access to anti-retroviral drugs, male in Paraguay?
- Access to anti-retroviral drugs, male in Paraguay was 61.0% in 2024, according to UNAIDS estimates.
- What is the highest access to anti-retroviral drugs, male recorded in Paraguay?
- The highest recorded value was 61.0% in 2024.
- What is the lowest access to anti-retroviral drugs, male recorded in Paraguay?
- The lowest recorded value was 0.0% in 2000.
- How does Paraguay rank for access to anti-retroviral drugs, male?
- Paraguay ranks 97th out of 141 countries with data for 2024.
- Is access to anti-retroviral drugs, male rising or falling in Paraguay?
- Over the last ten years it is up 103.3%. The long-run trend across the full record is volatile.
- Where does this Paraguay data come from?
- The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, male (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of adult males living with HIV who are receiving antiretroviral therapy.